by American College of Physicians Credit: Annals of Internal Medicine (2023). DOI: 10.7326/M22-2381 An analysis of a COVID-19 trial has found that a combination of symptoms and viral rebound after untreated COVID-19 infection is rare, occurring in only 3% of study participants. The analysis is published in Annals of Internal Medicine. Nirmatrelvir–ritonavir is a recommended treatment for outpatients...
